Tcelltech GmbH, a spin-out of the German Cancer Research Center (DKFZ), envisages developping a universal personalised adoptive cell therapy against all cancers (UNIPACT). UNIPACT is based on two platform technologies: (I) High performance gene expressing DNA vector (nanoSMAR) (II) AI bioinformatics platform for reactive T cell receptor identification (selecTCR). Managing Directors: Prof. Dr. Michael Platten, Dr. Edward Green, Dr. Richard Harbottle, Dr. Mathias Turwitt HRB 745600 AG Mannheim
| Website | https://www.tcelltech.eu/ |
| Employees | 4 (3 on RocketReach) |
| Founded | 2022 |
| Address | Franz-Volhard Straße 5, CUBEX ONE, Mannheim, Baden-Württemberg 68167, DE |
| Industry | Biotechnology Research |
| Keywords | Therapeutic Development, Cancer Therapy, Personalized Medicine, Precision Medicine, Immunotherapy, Cancer Research, Gene Editing, Clinical Trials, Platform Technology, Cell Engineering, Drug Development, Gene Therapy, Oncology, Life Sciences, Biotechnology, Molecular Biology, Pharmaceutical, Biopharma |
Looking for a particular Tcelltech GmbH employee's phone or email?
Tcelltech GmbH Questions
Edward Green is the Founder and Chief Scientific Officer of Tcelltech GmbH.
3 people are employed at Tcelltech GmbH.
Tcelltech GmbH is based in Mannheim, Baden-Württemberg.
Top Tcelltech GmbH Employees
-
Edward Green
Founder and Chief Scientific Officer at Tcelltech GmbH
Heidelberg, BW, DE3 -
11
-
Mathias Turwitt
Co-Founder, Finance at Tcelltech GmbH
Hamburg, HH, DE33
Related Companies
